Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1324.41% is 958% below its 3-year average of -125.23%, near the low end of its 3-year range (-1701.65%–0.00%).
106.66% below its 12-month average of -640.88%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -590.83%.
OPERATING MARGIN
-1324.41%
OPERATING MARGIN AVG TTM
-640.88%
OPERATING MARGIN AVG 3Y
-125.23%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-106.66%
CURRENT VS 3Y AVG
-957.60%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
NRx Pharmaceuticals, Inc.
Market Cap
$127.29M
Operating Margin
-1324.41%
TTM Avg
-640.88%
3Y Avg
-125.23%
5Y Avg
0.00%
Market Cap
$127.21M
Operating Margin
-609.18%
TTM Avg
-581.63%
3Y Avg
-290.81%
5Y Avg
-193.88%
Market Cap
$126.43M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$124.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$124.26M
Operating Margin
-959.05%
TTM Avg
-1156.66%
3Y Avg
-959.32%
5Y Avg
-639.55%
Market Cap
$130.16M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$131.30M
Operating Margin
-9.35%
TTM Avg
-5.78%
3Y Avg
-14.39%
5Y Avg
-45.18%
Market Cap
$131.53M
Operating Margin
-11.60%
TTM Avg
-17.18%
3Y Avg
-31.98%
5Y Avg
-39.70%
Market Cap
$121.25M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $127.29M | -1324.41% | -640.88% | -125.23% | 0.00% |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.21M | -609.18% | -581.63% | -290.81% | -193.88% |
| Entera Bio Ltd. (ENTX)vs › | $126.43M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.26M | -959.05% | -1156.66% | -959.32% | -639.55% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $130.16M | -7.85% | -2.10% | -0.51% | 4.29% |
| LifeMD, Inc. (LFMD)vs › | $131.30M | -9.35% | -5.78% | -14.39% | -45.18% |
| Health Catalyst, Inc. (HCAT)vs › | $131.53M | -11.60% | -17.18% | -31.98% | -39.70% |
| enGene Holdings Inc. (ENGN)vs › | $121.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Seer, Inc. (SEER)vs › | $121.23M | -483.85% | -600.79% | -640.11% | -1468.53% |
Gross Margin
58.8%
Operating Margin
-1324.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -590.83% |
| 2026-03-31 | -444.57% |
| 2025-12-31 | -467.34% |
| 2025-09-30 | -1701.65% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
